Thibaut Mongon - Nov 4, 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Signature
Raavi K. Deol, as attorney-in-fact for Thibaut Mongon
Stock symbol
JNJ
Transactions as of
Nov 4, 2022
Transactions value $
-$1,424,143
Form type
4
Date filed
11/8/2022, 03:59 PM
Previous filing
Mar 21, 2022
Next filing
Nov 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $2.41M +18.3K +45.58% $131.94 58.4K Nov 4, 2022 Direct
transaction JNJ Common Stock Options Exercise $2.2M +17K +29.02% $129.51 75.4K Nov 4, 2022 Direct
transaction JNJ Common Stock Sale -$2.9M -17K -22.49% $171.14 58.4K Nov 4, 2022 Direct F1
transaction JNJ Common Stock Sale -$3.13M -18.3K -31.31% $171.22 40.1K Nov 4, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $0 -18.3K -100% $0.00* 0 Nov 4, 2022 Common Stock 18.3K $131.94 Direct
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $0 -17K -100% $0.00* 0 Nov 4, 2022 Common Stock 17K $129.51 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $171.13 to $171.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $171.21 to $171.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.